BIO vs NVR · rev $651.0M vs P/E 15, rev $4.21B
BIO (BIO) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
BIO currently screens at market cap $0. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the BIO and NVR stock pages for the full models.
Not investment advice.